GATINEAU, QC, Aug. 18 /CNW Telbec/ - ImaSight Corp. (IAS:TSX-V) announced
today that its Liponex division has filed for patent protection of a novel
discovery related to its cardiovascular technology and initiated discussions
with three companies that have expressed an interest in acquiring the Liponex
technology.
